Your browser doesn't support javascript.
loading
Ebola virus dynamics in mice treated with favipiravir.
Madelain, Vincent; Oestereich, Lisa; Graw, Frederik; Nguyen, Thi Huyen Tram; de Lamballerie, Xavier; Mentré, France; Günther, Stephan; Guedj, Jeremie.
Afiliación
  • Madelain V; INSERM, IAME, UMR 1137, F-75018 Paris, France; Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, F-75018 Paris, France.
  • Oestereich L; Bernhard-Nocht-Institute for Tropical Medicine, 20359 Hamburg, Germany; German Centre for Infection Research (DZIF), Partner Site Hamburg, Germany.
  • Graw F; Center for Modeling and Simulation in the Biosciences, BioQuant-Center, Heidelberg University, 69120 Heidelberg, Germany.
  • Nguyen TH; INSERM, IAME, UMR 1137, F-75018 Paris, France; Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, F-75018 Paris, France.
  • de Lamballerie X; Aix Marseille Université, IRD French Institute of Research for Development, EHESP French School of Public Health, EPV UMR_D 190 "Emergence des Pathologies Virales", F-13385 Marseille, France; Institut Hospitalo-Universitaire Méditerranée Infection, F-13385 Marseille, France.
  • Mentré F; INSERM, IAME, UMR 1137, F-75018 Paris, France; Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, F-75018 Paris, France.
  • Günther S; Bernhard-Nocht-Institute for Tropical Medicine, 20359 Hamburg, Germany; German Centre for Infection Research (DZIF), Partner Site Hamburg, Germany.
  • Guedj J; INSERM, IAME, UMR 1137, F-75018 Paris, France; Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, F-75018 Paris, France. Electronic address: jeremie.guedj@inserm.fr.
Antiviral Res ; 123: 70-7, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26343011
The polymerase inhibitor favipiravir is a candidate for the treatment of Ebola virus disease. Here, we designed a mathematical model to characterize the viral dynamics in 20 mice experimentally infected with Ebola virus, which were either left untreated or treated with favipiravir at 6 or 8days post infection. This approach provided estimates of kinetic parameters of Ebola virus reproduction, such as the half-life of productively infected cells, of about 6h, and the basic reproductive number which indicates that virus produced by a single infected cell productively infects about 9 new cells. Furthermore, the model predicted that favipiravir efficiently blocks viral production, reaching an antiviral effectiveness of 95% and 99.6% at 2 and 6days after initiation of treatment, respectively. The model could be particularly helpful to guide future studies evaluating favipiravir in larger animals.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Pirazinas / Fiebre Hemorrágica Ebola / Carga Viral / Ebolavirus / Amidas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Antiviral Res Año: 2015 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Pirazinas / Fiebre Hemorrágica Ebola / Carga Viral / Ebolavirus / Amidas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Antiviral Res Año: 2015 Tipo del documento: Article País de afiliación: Francia